© 2020 MJH Life Sciences and Urology Times. All rights reserved.
Benign Conditions
AUA 2020: Disorders of ejaculation guidelines hailed as “most scientifically rigorous to date”
June 30, 2020
Alan W. Shindel, MD, provides an expert summary and analysis of the 2020 AUA Guidelines for Disorders of Ejaculation.
Rechargeable neuromodulation system safe and efficacious through 1 year
June 30, 2020
The reduction in urinary urgency incontinence episodes observed was “quite significant,” an investigator said.
Sulopenem hits key end point in phase 3 uncomplicated UTI trial
June 29, 2020
The novel oral penem anti-infective compound sulopenem showed stronger clinical activity than ciprofloxacin in patients with uncomplicated urinary tract infections with quinolone resistant pathogens, according to findings from the phase 3 SURE1 trial.
Dr. Weiss on defining nocturia and separating it from overactive bladder
June 26, 2020
In this interview, Gopal H. Badlani speaks to Jeffrey P. Weiss, MD, regarding how Weiss defines nocturia and separating the symptom from overactive bladder.
AUA updates guideline for surgical management of BPH-related lower urinary tract symptoms
June 25, 2020
The guidelines are an evidence-based clinical reference for the treatment of patients with lower urinary tract symptoms secondary to BPH.
Photoselective vaporization of the prostate found safe, durably effective
June 23, 2020
Only 1.5% of patients undergo repeat surgical intervention for BPH recurrence.
PROs favor prostatic urethral lift over water vapor ablation for BPH symptoms
June 22, 2020
Patient-reported outcomes showed a superior experience regarding post-procedure BPH symptoms with the UroLift prostatic urethral lift over Rezum tissue ablation with steam injection.
Minimally invasive treatments grab BPH spotlight
January 30, 2019
Minimally invasive surgical options took front and center in 2018 when the AUA published its revised guideline on the surgical management of male lower urinary tract symptoms secondary to BPH.
OAB patients continue medical therapy unnecessarily
November 20, 2018
A recent study found that sacral neuromodulation monotherapy was efficacious as a third-line treatment.